FDA inspection
Centrient Pharmaceuticals India Private Limited: FDA inspection ending Jul 1, 2022
FDA inspection 1175790 · Official Action Indicated (OAI) · Nawashahr
Key facts
| Inspection ID | 1175790 |
|---|---|
| Firm | Centrient Pharmaceuticals India Private Limited |
| FEI number | 3004497364 |
| Address | Bhai Mohan Singh Nagar, Village Toansa, District Sbs Nagar |
| City | Nawashahr |
| Country | India |
| Fiscal year | 2022 |
| Inspection end date | Jul 1, 2022 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 640196 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data